3-Month Discontinuation of Dual Antiplatelet Therapy after Ultimaster Sirolimus-Eluting Stent Implantation
Latest Information Update: 09 Jan 2019
At a glance
- Drugs Sirolimus (Primary)
- Indications Coronary artery disease
- Focus Therapeutic Use
- Acronyms MODEL U-SES
- 20 Jun 2018 Status changed from recruiting to active, no longer recruiting.
- 07 Nov 2016 Status changed from not yet recruiting to recruiting.
- 21 Jul 2016 New trial record